AAAAAA

   
Results: 1-11 |
Results: 11
ARMY AND AIR-FORCE LEADERSHIP IN THE PROSTATE-CANCER PREVENTION TRIAL
Authors: ALLERTON J SEAY T OPTENBERG S COLTMAN CA HIGGINS B THOMPSON I LOVATO L
Citation: J. Allerton et al., ARMY AND AIR-FORCE LEADERSHIP IN THE PROSTATE-CANCER PREVENTION TRIAL, Urology, 51(4A), 1998, pp. 64-66
BUSULFAN PHARMACOKINETICS IN PATIENTS UNDERGOING BONE-MARROW TRANSPLANT (BMT) - AN ANALYSIS OF THE EFFECTS OF UROSODIOL
Authors: SCHROEDER M JASLOWSKI A THOMAS A WARREN T LEWIS S ESSELL J HARMAN G ALLERTON J WILKS S OSSWALD M HALVORSON R
Citation: M. Schroeder et al., BUSULFAN PHARMACOKINETICS IN PATIENTS UNDERGOING BONE-MARROW TRANSPLANT (BMT) - AN ANALYSIS OF THE EFFECTS OF UROSODIOL, Blood, 88(10), 1996, pp. 3762-3762
THE BILI DAY INDEX (BDI) - A SIMPLIFIED WAY TO PREDICT LIFE-THREATENING VENO OCCLUSIVE DISEASE (VOD) ALLOGENIC BONE-MARROW TRANSPLANT (BMT)PATIENTS
Authors: SHAUGHNESSY P LEWIS S ALLERTON J SCHROEDER M
Citation: P. Shaughnessy et al., THE BILI DAY INDEX (BDI) - A SIMPLIFIED WAY TO PREDICT LIFE-THREATENING VENO OCCLUSIVE DISEASE (VOD) ALLOGENIC BONE-MARROW TRANSPLANT (BMT)PATIENTS, Blood, 88(10), 1996, pp. 3763-3763
INCREASED DOSE INTENSITY (DI) OF DOXORUBICIN AND VINBLASTINE DURING ABVD THERAPY OF HODGKINS LYMPHOMA WITH THE USE OF GRANULOCYTE-COLONY-STIMULATING FACTOR (GCSF)
Authors: RAYBON K SCHROEDER M ALLERTON J
Citation: K. Raybon et al., INCREASED DOSE INTENSITY (DI) OF DOXORUBICIN AND VINBLASTINE DURING ABVD THERAPY OF HODGKINS LYMPHOMA WITH THE USE OF GRANULOCYTE-COLONY-STIMULATING FACTOR (GCSF), Blood, 86(10), 1995, pp. 3270-3270
BONE-MARROW TRANSPLANTATION (BMT) IN MULTIPLE-MYELOMA (MM) WITH BUSULFAN (BU) AND CYCLOPHOSPHAMIDE (CY) - UNACCEPTABLE TOXICITY WITH STANDARD-DOSE IN HEAVILY PRETREATED PATIENTS
Authors: RAYBON K THOMAS A SCHROEDER M LEWIS S CHRISTMAN K WILKS S OSSWALD M ABBOTT K HALVORSON R ESSELL J ALLERTON J
Citation: K. Raybon et al., BONE-MARROW TRANSPLANTATION (BMT) IN MULTIPLE-MYELOMA (MM) WITH BUSULFAN (BU) AND CYCLOPHOSPHAMIDE (CY) - UNACCEPTABLE TOXICITY WITH STANDARD-DOSE IN HEAVILY PRETREATED PATIENTS, Blood, 86(10), 1995, pp. 3833-3833
BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH SEVERE APLASTIC-ANEMIA USING CYCLOPHOSPHAMIDE AND ANTITHYMOCYTE GLOBULIN (ATG)
Authors: SHAUGHNESSY P LEWIS S SCHROEDER M ALLERTON J WILKS S CHRISTMAN K OSSWALD M ABBOTT K HARMON G HALVORSON R SNYDER M CALLANDER N
Citation: P. Shaughnessy et al., BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH SEVERE APLASTIC-ANEMIA USING CYCLOPHOSPHAMIDE AND ANTITHYMOCYTE GLOBULIN (ATG), Blood, 86(10), 1995, pp. 3849-3849
SONOGRAPHIC FINDINGS IN PATIENTS WITH HEPATIC VENOOCCLUSIVE DISEASE
Authors: TURNER D SCHROEDER M ESSELL J ALLERTON J
Citation: D. Turner et al., SONOGRAPHIC FINDINGS IN PATIENTS WITH HEPATIC VENOOCCLUSIVE DISEASE, Blood, 86(10), 1995, pp. 3867-3867
A STUDY OF MIDCOUNTS AS PREDICTORS OF FINAL YIELD DURING THE HARVEST OF BONE-MARROW FOR TRANSPLANTATION
Authors: OSSWALD M DAVIS H ALLERTON J HALVORSEN R
Citation: M. Osswald et al., A STUDY OF MIDCOUNTS AS PREDICTORS OF FINAL YIELD DURING THE HARVEST OF BONE-MARROW FOR TRANSPLANTATION, Blood, 86(10), 1995, pp. 3947-3947
ALLOGENEIC BONE-MARROW TRANSPLANT (BMT) IN PATIENTS WITH CARDIAC DYSFUNCTION USING BUSULFAN AND ETOPOSIDE
Authors: BANE C HALVORSON R SCHROEDER M CALLANDER N ALLERTON J SNYDER M WILKS S CHRISTMAN K LEWIS S HARMAN G
Citation: C. Bane et al., ALLOGENEIC BONE-MARROW TRANSPLANT (BMT) IN PATIENTS WITH CARDIAC DYSFUNCTION USING BUSULFAN AND ETOPOSIDE, Blood, 84(10), 1994, pp. 10000704-10000704
DIRECTED GANCICLOVIR (DHPG) PROPHYLAXIS AGAINST CYTOMEGALOVIRUS (CMV)PNEUMONITIS IN PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: SCHROEDER M ESSELL J HARMAN G HALVORSON R DOLAN M CALLANDER N SNYDER M WILKS S ALLERTON J THOMPSON J
Citation: M. Schroeder et al., DIRECTED GANCICLOVIR (DHPG) PROPHYLAXIS AGAINST CYTOMEGALOVIRUS (CMV)PNEUMONITIS IN PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 82(10), 1993, pp. 10000425-10000425
DISTURBANCES OF COAGULATION-FACTORS WITH BONE-MARROW TRANSPLANTATION (BMT) - A POSSIBLE LINK TO THE GENESIS OF VENOOCCLUSIVE DISEASE OF THELIVER (VOD)
Authors: WILKS S ESSELL J MCGLASSON D HARMAN G HALVORSON R CALLANDER N SNYDER M ALLERTON J
Citation: S. Wilks et al., DISTURBANCES OF COAGULATION-FACTORS WITH BONE-MARROW TRANSPLANTATION (BMT) - A POSSIBLE LINK TO THE GENESIS OF VENOOCCLUSIVE DISEASE OF THELIVER (VOD), Blood, 82(10), 1993, pp. 10000623-10000623
Risultati: 1-11 |